NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT04498520 2021-05-18Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerUniversity of California, San FranciscoPhase 1 Withdrawn